Annovis Bio, Inc. Public Float
Annovis Bio, Inc. (ANVS) had Public Float of $36.08 million as of 2025-06-30, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $36.08M.
- 2024-06-30: Entity Public Float $51.31M.
- 2023-06-30: Entity Public Float $91.53M.
- 2022-06-30: Entity Public Float $63.48M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $36.08M 10-K · filed 2026-03-13 |
| 2024-06-30 | $51.31M 10-K · filed 2025-03-21 |
| 2023-06-30 | $91.53M 10-K · filed 2024-03-29 |
| 2022-06-30 | $63.48M 10-K · filed 2023-03-31 |
| 2021-06-30 | $481.82M 10-K · filed 2022-03-02 |
| 2020-06-30 | $18.69M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |